Madlaina Breuleux

Madlaina Breuleux is a Principal Clinical Scientist and Clinical Science Lead at Roche, where they provide support for late-stage clinical trial strategy and execution in the field of multiple myeloma. With 24 years of experience in Oncology and Hemato-Oncology, they have worked in academia and industry, holding various roles that span preclinical and clinical research as well as medical affairs. Madlaina has previously held positions at companies such as Gilead Sciences and GlaxoSmithKline, and they have contributed to numerous international clinical trials and projects. They earned a Ph.D. in Molecular Biology from the University of Basel and have additional qualifications in Pharmaceutical Medicine.